Frederik Denorme։ PhD Position in Translational Stroke Research at the University of Antwerp
Frederik Denorme, Tenure Track Assistant Professor at University of Antwerp, shared a post on LinkedIn:
”PhD Position in Translational Stroke Research
We are looking for a motivated PhD candidate to join our research group at the Laboratory of Cell Biology and Histology (CBH), University of Antwerp.
This project focuses on translational ischemic stroke research, combining innovative humanized mouse models with samples from stroke patients to understand how the detrimental interaction between thrombosis and the immune system drives brain injury and disease progression after stroke.
The successful candidate will be embedded in a dynamic and multidisciplinary research environment within the Laboratory of Cell Biology and Histology (CBH). The project will closely interact with the Antwerp Centre for Advanced Microscopy (ACAM), providing access to state-of-the-art imaging technologies.
Within the University of Antwerp, our team is also embedded in the µNEURO Research Centre of Excellence, offering a strong multidisciplinary platform for integrative and translational neuroscience research.”
Stay updated with Hemostasis Today.
-
Apr 24, 2026, 17:30Omar Adwan: Easy-to-Remember Tips for MCV
-
Apr 24, 2026, 17:07Melissa Hollo: Revolutionizing Diagnostics Through Real-Time Anemia Management at Executive War College
-
Apr 24, 2026, 17:03Oscar William-Donkor: Faith, Blood and Choice
-
Apr 24, 2026, 17:01Julie Rayes: Presenting Our Data at the 12th Symposium on Hemostasis
-
Apr 24, 2026, 16:56Nazish Saqlain: Hands-on Training Workshop in Transfusion Medicine and Immunohematology
-
Apr 24, 2026, 16:49Michael Greger: Most Heart Attacks Are Triggered by Non-Obstructive Plaques
-
Apr 24, 2026, 16:06Maxime Dely: Venous Access in Apheresis Technology Isn’t Everything
-
Apr 24, 2026, 15:12Jim Hoffman: Linking Post-Acute Chronic Infection Brain Injury and Autoimmune Dysregulation
-
Apr 24, 2026, 15:11Ensuring That Science Translates Into Real Impact for Patients – EAHAD